Graham Collins, Associate Professor, Haematology and Lymphoma Specialist at Oxford Cancer and Haematology Centre, shared a post on X:
“Sorial et al: time to relapse within 12mo (TTR12) as survival indicator in T-cell lymphoma
- PETAL consortium, 452 pts & approx 300 for validn
- Had to have CR to 1L Rx
- TTR12 pts had worse OS irrespective of histology, PIT, prior ASCT
Not surprising but useful.”
More posts featuring Graham Collins on OncoDaily.
